Clinical Trial Update: Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluated perioperative exenatide infusion and its impact on quality of life in cardiac surgery patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery Complications
• Heart Disease

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Quality of Life | Phase 2, Phase 3 | Status: COMPLETED